Skip to content
Tiopronin
Thiola (tiopronin) is a small molecule pharmaceutical. Tiopronin was first approved as Thiola on 1988-08-11.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Thiola (generic drugs available since 2021-04-26)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Tiopronin
Tradename
Company
Number
Date
Products
THIOLAMission PharmacalN-019569 RX1988-08-11
1 products, RLD, RS
THIOLA ECMission PharmacalN-211843 RX2019-06-28
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
thiola ecNew Drug Application2021-03-15
tioproninANDA2021-02-17
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
TIOPRONIN, THIOLA, MISSION PHARMA
2026-06-28ODE-267
TIOPRONIN, THIOLA EC, MISSION PHARMACAL CO
2026-06-28ODE*
Patent Expiration
Patent
Expires
Flag
FDA Information
Tiopronin, Thiola Ec, Mission Pharmacal Co
114581042038-11-14U-3441
ATC Codes
G: Genito urinary system and sex hormones
— G04: Urologicals
— G04B: Urologicals
— G04BX: Other urologicals in atc
— G04BX16: Tiopronin
HCPCS
No data
Clinical
Clinical Trials
27 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544—12619
Bacterial vaginosisD016585EFO_00039321121—5
GiardiasisD005873DOID_10718A07.1———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Helicobacter infectionsD016481EFO_1000961——1——1
GastritisD005756EFO_0000217K29.7——1——1
Stomach neoplasmsD013274EFO_0003897C16——1——1
CandidiasisD002177B37——1——1
VaginitisD014627EFO_0005757N76——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
UrethritisD014526EFO_0003878N34—1———1
Vivax malariaD016780EFO_0007445B51—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Trichomonas infectionsD014245DOID_1947A591————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Disease susceptibilityD004198————11
Abdominal painD015746R10.9————11
HysterectomyD007044EFO_0003881————11
Trichomonas vaginitisD014247EFO_0007521————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTIOPRONIN
INNtiopronin
Description
Tiopronin is a N-acyl-amino acid.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(S)C(=O)NCC(=O)O
Identifiers
PDB—
CAS-ID1953-02-2
RxCUI6765
ChEMBL IDCHEMBL1314
ChEBI ID32229
PubChem CID5483
DrugBankDB06823
UNII IDC5W04GO61S (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Tiopronin - Travere Therapeutics
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 699 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
198 adverse events reported
View more details